New startup ideas · Consumer and commerce · Consumer
startup idea
Talvia
FDA-cleared autonomous AI therapy, sold to health plans at one-tenth the cost.
Talvia builds a clinically validated conversational AI that delivers protocolized CBT for anxiety and depression as a covered insurance benefit, replacing 150-dollar-per-session human therapy with a 15-dollar-per-member-per-month product.
- Software subscription
- Enterprise
- $10-100B market
- Collapses a cost 10x
- US first
5/5
venture judge
11
similar startups, last 2 years (61 all-time)
92%
of 2 nearest real companies still alive
yes
8 matching federal grants and programs
Direction supported by government programs and grants
Scorecard
One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.
70
Idea Score, 0-100 · raw 42.8 x 1.64
Crowded
competition: more crowded than 75% of ideas · headwind x0.63
+4.5
government priorities, secondary (110 matching grants)
Trend
45
Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.
- Entrants 2025-26 vs 2023-24 (similar companies)51
- Rounds announced 2025+ in the sector25
- Rounds announced 2025+ matching the idea98
- Sector direction (live batch)0
- 2026 trend analyst50
Demand
70
Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.
- YC asks for it (current RFS: idea / sector)60
- Someone already pays (similar companies, recent / all-time)100
- Operator judge: real pain50
100x potential
72
Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.
- Venture judge100
- Market size axis67
- Moat axis80
- Neighbours still alive38
- Technologist judge50
Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were fda-cleared, autonomous, therapy, sold, health, plans, one-tenth, cost.
The idea in full
- What
- Talvia builds a clinically validated conversational AI that delivers protocolized CBT for anxiety and depression as a covered insurance benefit, replacing 150-dollar-per-session human therapy with a 15-dollar-per-member-per-month product. It sells to national health plans and large employer programs through benefits brokers and consultants, and runs clinical operations and safety-monitoring teams alongside the software. The first three-plus years are clinical trials and FDA software-as-a-medical-device clearance; revenue follows the clearance, and the clearance plus payer contracts are the moat.
- Why now
- Whoop's 575M Series G in 2026 shows the scale of consumer spend on health, and the YC X26 batch includes ANORIA (a wearable that reads emotions) and Napkin Math (an AI nutrition coach) - AI coaching for consumers is a wave, but none of these carries clinical clearance, so none can be a reimbursed benefit, which is where behavioral health money actually sits.
- Wedge: first customer and entry point
- Run the pivotal trial on a single indication - moderate anxiety - with one regional health plan as trial partner and first customer, a scope a small founding team with one clinical lead can carry to clearance.
- Path to 100x
- US behavioral health spend is in the tens of billions against a structural therapist shortage, so a 10x cost collapse is the only way supply ever meets demand, and payers are the buyers who capture that saving. The company that clears FDA first and signs national plans owns the covered category for the years it takes anyone else to repeat the trials, which is how a licensing moat compounds into winner-takes-most.
- Ceiling
- Payers may cap per-member pricing aggressively once a second cleared competitor exists, compressing this into a sub-billion contract business.
- Closest real companies, as the generator saw them
- ANORIA and Napkin Math are consumer wellness products with no clinical claims or payer channel; Whoop sells hardware subscriptions to individuals. Talvia competes with human therapist supply, not with any company in the brief.
- Main risk
- A single high-profile safety failure in autonomous mental health AI triggers a regulatory freeze that stalls the category for years.
Five judges
Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).
Venture investor
5/5
FDA clearance plus national payer contracts in a tens-of-billions behavioral health pool is a compounding license moat with genuine winner-takes-most upside.
Bootstrapper
1/5
Pivotal trials and SaMD clearance before any payer contract is the longest regulatory path on the board.
Operator
3/5
Payers own the budget and feel the $150-per-session cost, but the pivotal trial and SaMD clearance defer revenue past three years.
Technologist
3/5
Pivotal trials and SaMD clearance are a genuine multi-year barrier, but the underlying protocolized CBT chatbot is not itself hard to build.
Risk
2/5
No revenue until FDA SaMD clearance, then a handful of national payers as buyers, with one safety incident able to freeze the category.
trends
3/5
Behavioral health rides the $590M healthcare grant pool, but a Whoop consumer raise is no payer-side shift and FDA-cleared digital CBT predates 2023.
Similar startups in the directory
Companies whose pitch matches most of the idea's terms (fda-cleared, autonomous, therapy, sold, health, plans, one-tenth, cost): 61 all-time, 11 from the last two years. Same matching as Idea Check.
Psychotherapy through autonomous and personalized VR-sessions.
Avenda Health offers Unfold AI, an FDA-cleared platform that generates patient-specific 3D cancer maps to aid urologists in planning and executing personalized prostate cancer treatments.
Cambrian Project provides services in Business automation by service robots , AI/IoT technology project & Service/application development.
RNARevive is developing a next-generation RNA platform that enables long-lasting, low-dose protein therapeutics. Our lead candidates tackle the anti-aging and longevity space, targeting osteoporosis, age-related macular degeneration (AMD), and liver diseases.
Healthcare for the age of abundant intelligence.
The AI for ER workflows.
Counter Drone Systems. $1.6m sales. We delivered for the DoW.
Automating claims processing workflows for health insurance payers.
Autonomous Agents for Healthcare
Trial Library is an oncology clinical trials company.
We audit medical claims for self-insured employers and health plans.
Outfox Health is an enterprise AI platform that helps health plans & self-funded employers recapture $238 billion lost from poor care navigation by giving their members & care navigators instant, personalized guidance on benefits, providers, and costs.
The generator's reference companies
Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.
Public money in this direction
US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.
8
grants and programs matching the idea
29
startup-relevant grants in Consumer
$8M
awarded in the sector, tracked
- Personalized Diabetes Management through iPSC-Derived β-cells: A Tailored Approach for Improving Treatment Efficacy in Economically Vulnerable Populationsawardhigh relevance
NIH / NIDDK · SBIR phase I · $307K · posted 2026-08-15
- Accelerating Time-to-Treatment in Rural Areas with a Pre-Hospital EEG Stroke Classification Systemawardhigh relevance
NIH / NIMHD · STTR phase I · $314K · posted 2026-08-05
- SBIR Phase II: AI-Driven Visualization of Rehabilitation Documentation to Support Decision-Making Across Care Settingsawardhigh relevance
National Science Foundation · SBIR Phase II · $1M · posted 2026-07-20
- Developing GLP-1 Producing Genetically Engineered Probiotics for Treatment of Metabolic Diseasesawardhigh relevance
NIH / NIDDK · SBIR phase I · $356K · posted 2026-07-15
- An Internet of Things Automated Cognitive Behavioral Therapy for Insomnia that Improves Cognition in Older Adultsawardhigh relevance
NIH / NIA · SBIR phase I · $500K · posted 2025-09-20
- I-Corps: Translation Potential of an Artificial Intelligence (AI)-Enabled Autonomous Subsea Connection Systemawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-17
NIH / NIDA · SBIR phase I · $400K · posted 2026-08-15
- INHERET: Commercialization and EHR Integration of an Innovative Personalized Medicine Tool to Advance Cancer Screening and Managementawardhigh relevance
NIH / NCI · SBIR phase II · $1M · posted 2026-08-14
Market signal
What the radar sees in Consumer: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.
Consumer · 170 → 218 → 206 → 153 → 49 new companies 2022 → 2026 · 87% aliveYC S26: 8 in this cluster, 3% of the batch (was 5% in X26) (F26 is still forming: 21 listed)Since February, of 787 YC companies here: 2 acquired, 4 shut down, 37 rewrote their pitch
Design attributes
The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.
- Buyer
- Enterprise
- Business model
- Software subscription
- Path to 100x
- Collapses a cost 10x
- Market size
- $10-100B market
- Capital intensity
- Capital-medium (ops, field teams)
- Speed to revenue
- R&D first, revenue after 3 years
- Technical depth
- Deep tech: ML, hardware, bio
- Go-to-market
- Partners and channels
- Moat
- License or regulatory moat
- Geography
- US first
- Regulation
- Heavily regulated
- Vibe
- Hot space
Listed under
An idea sits in its own sector and in any sector its text clearly touches.
More ideas like this
Consumer and commerce · Consumer
Yearmark
Certified on-device age assurance and minor-safety controls, shipped as one SDK for consumer apps.
Yearmark is a subscription SDK that consumer app companies drop into signup and payment flows to estimate a user's age band on-device from face, voice and interaction signals, then enforce the right minor-safety rules per jurisdiction without sending biometrics to a server.
Consumer and commerce · Consumer
Listwire
One API that lists any secondhand item everywhere and prices it from real comps.
Small resellers and secondhand shops connect once to Listwire and their inventory appears, correctly categorised and priced, across every consumer resale marketplace, with orders, cancellations and payouts flowing back through the same endpoints.
Consumer and commerce · Consumer
Fidara
A licensed AI fiduciary that manages your entire financial life, legally on your side.
Fidara is a consumer AI agent registered as an investment advisor and licensed money transmitter, so it can actually move money, rebalance accounts, refinance debt, contest bills and file the paperwork - not just suggest.
Consumer and commerce · Consumer
Perpetua
A marketplace for persistent AI worlds that remember every player who visits.
Perpetua trains a real-time interactive world model with durable state, so a generated world keeps its geography, characters and consequences between sessions and across different visitors.
Consumer and commerce · Consumer
Castmark
Global marketplace where brands license AI-ready characters, voices and likenesses per use.
Castmark lists characters, voice models and performer likenesses with machine-readable licence terms (territory, media, duration, prohibited uses) and sells them per generation or per campaign to game studios, publishers and consumer brands.
Consumer and commerce · Consumer
Vaultline
Instant marketplace for vaulted collectibles: buy, sell and settle without ever shipping.
Consumers deposit graded cards and sealed hobby product into a partner bonded vault once; after that, ownership transfers instantly on Vaultline's ledger and nothing moves physically until an owner requests withdrawal.
Fictional company written 2026-08-26 from MarkosWeb data; the companies, grants and numbers around it are real and tracked. Treat the idea as a research prompt, not a plan.